<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Metabolomics</journal-id><journal-id journal-id-type="iso-abbrev">Metabolomics</journal-id><journal-title-group><journal-title>Metabolomics</journal-title></journal-title-group><issn pub-type="ppub">1573-3882</issn><issn pub-type="epub">1573-3890</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28867988</article-id><article-id pub-id-type="pmc">5562775</article-id><article-id pub-id-type="publisher-id">1247</article-id><article-id pub-id-type="doi">10.1007/s11306-017-1247-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Identification of weak and gender specific effects in a short 3&#x000a0;weeks intervention study using barley and oat mixed linkage &#x003b2;-glucan dietary supplements: a human fecal metabolome study by GC-MS</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3154-2198</contrib-id><name><surname>Trimigno</surname><given-names>Alessia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Khakimov</surname><given-names>Bekzod</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mejia</surname><given-names>Josue Leonardo Castro</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mikkelsen</surname><given-names>Mette Skau</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kristensen</surname><given-names>Mette</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Jespersen</surname><given-names>Birthe M&#x000f8;ller</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Engelsen</surname><given-names>S&#x000f8;ren Balling</given-names></name><address><email>se@food.ku.dk</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0674 042X</institution-id><institution-id institution-id-type="GRID">grid.5254.6</institution-id><institution>Department of Food Science, Faculty of Science, </institution><institution>University of Copenhagen, </institution></institution-wrap>Rolighedsvej 26, 1958 Frederiksberg C, Denmark </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1757 1758</institution-id><institution-id institution-id-type="GRID">grid.6292.f</institution-id><institution>Department of Agricultural and Food Sciences, </institution><institution>Alma Mater Studiorum - University of Bologna, </institution></institution-wrap>Piazza Goidanich 60, 47521 Cesena (FC), Italy </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0674 042X</institution-id><institution-id institution-id-type="GRID">grid.5254.6</institution-id><institution>Department of Nutrition, Exercise, and Sports, Faculty of Science, </institution><institution>University of Copenhagen, </institution></institution-wrap>Rolighedsvej 26, 1958 Frederiksberg C, Denmark </aff></contrib-group><pub-date pub-type="epub"><day>18</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="ppub"><year>2017</year></pub-date><volume>13</volume><issue>10</issue><elocation-id>108</elocation-id><history><date date-type="received"><day>12</day><month>6</month><year>2017</year></date><date date-type="accepted"><day>5</day><month>8</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><sec><title>Introduction</title><p>Mixed-linkage (1&#x02192;3),(1&#x02192;4)-&#x003b2;-<sc>d</sc>-glucans (BG) reduce cholesterol level and insulin response in humans. Despite this, their role in human metabolism and a mode of action remains largely unknown.</p></sec><sec><title>Objectives</title><p>To investigate the effects of three structurally different BG on human fecal metabolome in a full cross-over intervention using GC-MS metabolomics.</p></sec><sec><title>Methods</title><p>Over three weeks of intervention, young healthy adults received food supplemented with BG from oat, two different BG from barley or a non-fiber control in a full cross-over design. Untargeted metabolomics and short chain fatty acid analysis was performed on day three fecal samples. ANOVA-simultaneous component analysis was applied to partition the data variation according to the study design, and PLS-DA was used to select most discriminative metabolite markers.</p></sec><sec><title>Results</title><p>Univariate and multivariate data analysis revealed a dominating effect of inter-individual variances followed by a gender effect. Weak effects of BG intake were identified including an increased level of gamma-amino-butyrate and palmitoleic acid in males and a decreased level of enterolactone in females. Barley and oat derived BG were found to influence the human fecal metabolome differently. Barley BG increased the relative level of formate in males and isobutyrate, isovalerate, 2-methylbutyrate in females. In total 15, 3 and 11 human fecal metabolites were significantly different between control vs. BG, control vs. oat BG, and barley BG vs. oat BG, respectively.</p></sec><sec><title>Conclusions</title><p>The study show that human fecal metabolome largely reflects individual (&#x0223c;28% variation) and gender (&#x0223c;15% variation) differences, whereas the treatment&#x000a0;effect of the BG (&#x0223c;8% variation) only manifests in a few key metabolites (primarily by the metabolites: d-2-aminobutyric acid, palmitoleic acid, linoleic acid and 11-eicosenoic acid).</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1007/s11306-017-1247-2) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Mixed linkage &#x003b2;-glucan</kwd><kwd>Short chain fatty acids</kwd><kwd>Fecal metabolome (GC-MS)</kwd><kwd>Chemometrics</kwd><kwd>ASCA</kwd></kwd-group><funding-group><award-group><funding-source><institution>Danish Strategic Research Council/Innovation Foundation Denmar</institution></funding-source><award-id>4105-00015B</award-id><principal-award-recipient><name><surname>Engelsen</surname><given-names>S&#x000f8;ren Balling</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media, LLC 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Mixed-linkage (1&#x02192;3),(1&#x02192;4)-&#x003b2;-<sc>d</sc>-Glucans (BG) have been investigated in in vivo and in vitro studies, for their functional properties and health beneficial effects (Chen and Raymond <xref ref-type="bibr" rid="CR9">2008</xref>; Daou and Zhang <xref ref-type="bibr" rid="CR10">2012</xref>). BG are plant cell-wall polysaccharides and have been proven to exert beneficial effects in the gastro-intestinal tract (Cloetens et al. <xref ref-type="bibr" rid="CR01">2012</xref>; Lam and Cheung <xref ref-type="bibr" rid="CR39">2013</xref>) due to their physicochemical properties in aqueous environment such as thickening and gelling agent (Izydorczyk and Biliaderis <xref ref-type="bibr" rid="CR25">2000</xref>). The reported bioactivities of BG include: (1) lowering of the post-prandial blood insulin and glucose levels (Battilana et al. <xref ref-type="bibr" rid="CR3">2001</xref>; Jenkins et al. <xref ref-type="bibr" rid="CR27">2002</xref>; Frank et al. <xref ref-type="bibr" rid="CR18">2004</xref>; Biorklund et al. <xref ref-type="bibr" rid="CR7">2005</xref>; Beck et al. <xref ref-type="bibr" rid="CR5">2009a</xref>), (2) decrease of the cholesterol level in hypocholestorolaemic humans as well an in animals (Kalra and Jood <xref ref-type="bibr" rid="CR29">2000</xref>; Kerckhoffs et al. <xref ref-type="bibr" rid="CR32">2002</xref>; Delaney et al. <xref ref-type="bibr" rid="CR13">2003</xref>; Bi&#x000f6;rklund et al. <xref ref-type="bibr" rid="CR7">2005</xref>; Queenan et al. <xref ref-type="bibr" rid="CR51">2007</xref>), (3) reduction of blood pressure (Keenan et al. <xref ref-type="bibr" rid="CR30">2002</xref>; Liatis et al. <xref ref-type="bibr" rid="CR40">2009</xref>) and (4) increased cholecystokinin production (Bourdon et al. <xref ref-type="bibr" rid="CR8">1999</xref>; Beck et al. <xref ref-type="bibr" rid="CR5">2009a</xref>). It has been hypothesized that the ingestion of large amount of BG can only induce modest alteration in human blood (Battilana et al. <xref ref-type="bibr" rid="CR3">2001</xref>).</p><p>Despite the rich literature about the health beneficial effects of BG, a number of studies have not been able to show significant effects of BG. Frank et al. (Frank et al. <xref ref-type="bibr" rid="CR18">2004</xref>), investigated the effects of two oat-derived BG on blood lipids, glucose, insulin and tocopherol where BG showed no effect. Queenan et al. (<xref ref-type="bibr" rid="CR51">2007</xref>) studied concentrated oat BG and observed that this soluble dietary fiber did not influence blood glucose and insulin concentration, weight, homocysteine and C-Reactive protein. Ibr&#x000fc;gger et al. (<xref ref-type="bibr" rid="CR24">2013</xref>) showed that BG do not lower a cholesterol level in young healthy adults after 3-weeks of BG consumption (3.3&#x000a0;g/day), and in a follow-up study Mikkelsen et al. (Mikkelsen et al. <xref ref-type="bibr" rid="CR47">2014</xref>) showed no systematic metabolic differences between BG and control group using NMR metabolomics of blood plasma.</p><p>While the reasons for many no-effect studies may be multi-facetted, including lack of power and the use of inappropriate study design, the health beneficial potential of BG still calls for debate and the mechanisms are still under investigation. The health beneficial effects of BG have been related to their unique molecular block structures (Wood <xref ref-type="bibr" rid="CR60">2007</xref>; Sullivan et al. <xref ref-type="bibr" rid="CR54">2013</xref>). The difference between the barley and oat BG relies primarily in their block ratio of cellotriosyl and cellotetraosyl units connected by &#x003b2;-<sc>d</sc>-(1&#x02192;3) linkages (Mikkelsen et al. <xref ref-type="bibr" rid="CR46">2013</xref>). This ratio is generally lower in oat than in barley and it is considered as an important molecular parameter of the BG (Hughes et al. <xref ref-type="bibr" rid="CR23">2008</xref>). This variation also depends on the specific plant genotype (Mikkelsen et al. <xref ref-type="bibr" rid="CR46">2013</xref>) and growing conditions (Herrera et al. <xref ref-type="bibr" rid="CR21">2016</xref>). Oat BG have a higher water solubility than barley BG (Mikkelsen et al. <xref ref-type="bibr" rid="CR46">2013</xref>) and it is thus possible that BG from different sources with various structures and physicochemical properties may have a different impact on the metabolism of the host. Moreover, it has not been studied yet whether the effects of BG depend on the phenotype of the host.</p><p>This study investigates the same human intervention study as described in Ibr&#x000fc;gger et al. (<xref ref-type="bibr" rid="CR24">2013</xref>) and Mikkelsen et al. (<xref ref-type="bibr" rid="CR47">2014</xref>). The study included three BG derived from oat, mother-line barley (BOMI) and a mutant barley (<italic>lys5.f</italic>) which were provided as supplements to low-fat yogurt or blackcurrant-syrup beverage and the same product was investigated without the addition of any BG as a control. While the previous two studies were focused on the blood metabolome, this study investigates effects of the BG on the fecal metabolome. It is hypothesized that the human fecal metabolome which is less influenced by homeostasis, may exhibit significant excretion effects related to the BG supplement intake. The fecal metabolome has until recently not been scrutinized in great detail, but it represents a direct reflection of the crucial function of the gut and its microbiota to human health (Xu et al. <xref ref-type="bibr" rid="CR61">2014</xref>). Dietary fibers such as BG are known to be fermented by the microbiota into SCFA, which can be used by the mammalian host to produce the aforementioned beneficial effects. It is thus of fundamental interest to investigate whether the fecal metabolome is affected by the BG intake, and if so, how it is modulated by the different BG preparations. This study employs untargeted GC-MS metabolomics as well as GC-MS analysis of short-chain fatty acids (SCFA) along with advanced multivariate data analysis in order to study possible effects of BG on the fecal metabolome in humans.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Experimental design</title><p>The study design was single-blinded, randomized and 4-armed cross-over and each treatment lasted 3 weeks and had at least 2 weeks of wash-out period (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). The 16 recruited subjects were normo-cholesterolaemic and followed their normal dietary habits apart from a few restrictions (Ibr&#x000fc;gger et al. <xref ref-type="bibr" rid="CR24">2013</xref>). The study was designed based on a power calculation (Kristensen et al. <xref ref-type="bibr" rid="CR36">2011</xref>, <xref ref-type="bibr" rid="CR35">2012</xref>) in order to assess total cholesterol differences with sufficient power and allowing a 10% drop-out rate. Fourteen subjects completed the study (eight females and six males). The experimental design is described in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>.</p><p>
<fig id="Fig1"><label>Fig. 1</label><caption><p>Design of experiment. The trial is a randomized full cross-over, where the subjects undergo 3-weeks interventions of each treatment, followed by a 2-weeks wash-out period. Fecal samples are collected during the 3 days period before the treatment started and during the last 3 days period of each intervention. The treatments consisted of: mother barley BG (<bold>a</bold>), oat BG (<bold>b</bold>), control (<bold>c</bold>) and mutant barley BG (<bold>d</bold>)</p></caption><graphic xlink:href="11306_2017_1247_Fig1_HTML" id="d29e499"/></fig>
</p><p>The oat BG were purified from a concentrate (Promoat&#x02122;; Biovelop, Kimstad, Sweden) and barley BG were obtained either from a mother line BOMI (6% BG) or a mutant line <italic>lys5.f</italic> (16.5&#x02013;19.8% BG) (Munck et al. <xref ref-type="bibr" rid="CR48">2004</xref>). The isolation of BG from grains was obtained by hot water and enzymatic hydrolysis, employing a modified procedure from Kvist and Lawther (Kvist and Lawther <xref ref-type="bibr" rid="CR37">2011</xref>), as described by Mikkelsen et al. (<xref ref-type="bibr" rid="CR46">2013</xref>). The pre-hydrated BG preparations were given to the participants as a beverage with blackcurrant syrup (Minimum<sup>&#x000ae;</sup>) or as a low-fat vanilla yoghurt (Arla Cheasy<sup>&#x000ae;</sup>), with 1.65&#x000a0;g of BG per preparation, thus allowing the subjects to take the recommended daily dose of at least 3&#x000a0;g of BG (21 CFR 101.81, 62 FR 3584, January 23 <xref ref-type="bibr" rid="CR14">1997</xref>; EFSA Journal <xref ref-type="bibr" rid="CR16">2010</xref>).</p></sec><sec id="Sec4"><title>Metadata collection</title><p>The diet of each participant was recorded for 4 days and entered into the Dankost 3000 dietary assessment software (Dankost 3000, version 2.5; Danish Catering Center), in order to calculate the mean global intake of energy and macronutrients (carbohydrates, fats, proteins and alcohol) and fibers. Twenty-four blood parameters, including fasting concentrations of total, HDL and LDL cholesterol, plasma glucose and triacylglycerides were measured as reported by Mikkelsen et al. (<xref ref-type="bibr" rid="CR47">2014</xref>).</p><p>Fecal samples were collected during 3 days, both before and after intervention (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Fecal samples of each participant collected during the 3 days period were pooled and energy was measured using a bomb calorimeter (Ika-calorimeter system C4000; Heitersheim). One sample from a participant, collected in one out of 3&#x000a0;days period, was used for pH measurement (PH-208; Lutron Electonic Enterprise) after being mixed with demineralized water (1:1) and homogenized. Further description of samples collection and analysis are reported elsewhere (Ibr&#x000fc;gger et al. <xref ref-type="bibr" rid="CR24">2013</xref>; Mikkelsen et al. <xref ref-type="bibr" rid="CR47">2014</xref>). The final metadata variables consisted of blood parameters, anthropometric measurements [height, weight, age, body mass index (BMI)], dietary information (levels of hunger, satiety, fullness) and fecal parameters (e.g. pH, energy, weight, frequency).</p></sec><sec id="Sec5"><title>GC-MS analysis</title><p>Untargeted GC-TOF-MS metabolomics of fecal slurry was performed on 1&#x000a0;ml fecal slurry which was mixed with 1&#x000a0;ml of a buffer followed by freeze dying and methanol extraction. Following a two step derivatization, methoximation and trimethylsilylation, the samples were analyzed using a HT Pegasus GC-TOF-MS system (LECO Corporation, Saint Joseph, USA). Targeted analysis of fecal SCFAs was performed using 0.5&#x000a0;ml of fecal slurry, which was mixed with 1&#x000a0;ml of 0.3&#x000a0;M oxalic acid and analyzed by GC-MS (Agilent Technologies, California, USA). The Detailed description of the GC-MS analysis is given in the Supplementary Material.</p></sec><sec id="Sec6"><title>Data analysis</title><p>The data generated from the untargeted GC-TOF-MS metabolomics, targeted SCFA analysis, and metadata variables were analyzed individually as well as combined using univariate, including ANOVA, and multivariate, principal component analysis (PCA) (Hotelling <xref ref-type="bibr" rid="CR22">1933</xref>) and partial least squares-discriminant analysis (PLS-DA) (St&#x000e5;hle and Wold <xref ref-type="bibr" rid="CR53">1987</xref>), data analysis methods. According to the experimental design (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>), several factors including BG treatment (TR), gender (<bold>GN</bold>), and individual variations (<bold>IN</bold>), and their two and higher order interactions may contribute to a significant variation. Subsequently, these variations may confound or interact with BG related metabolic changes. Therefore, ANOVA-simultaneous component analysis (ASCA) (Smilde et al. <xref ref-type="bibr" rid="CR52">2005</xref>) was performed for partitioning variations in the data into several effect matrices (e.g. <bold>X</bold>
<sub><bold>TR</bold></sub>, <bold>X</bold>
<sub><bold>GN</bold></sub>, <bold>X</bold>
<sub><bold>IN</bold></sub>) using the study design. Subsequently each effect matrix was further evaluated using PCA and PLS-DA as described in the previous study (Khakimov et al. <xref ref-type="bibr" rid="CR34">2016</xref>). PLS-DA based classification models, using variable selection, were developed for identification of metabolite markers related to the BG treatment, using delta metabolomics data, <bold>&#x00394;X</bold>&#x02009;=&#x02009;<bold>X</bold>
<sub><bold>T1</bold></sub>&#x02009;&#x02212;&#x02009;<bold>X</bold>
<sub><bold>T0</bold></sub>, where <bold>X</bold>
<sub><bold>T0</bold></sub> is the measurement before the intervention started and <bold>X</bold>
<sub><bold>T1</bold></sub> is the measurement after the intervention. The GC-MS data were autoscaled before multivariate data analysis which was performed using Matlab (R2014b The Mathworks Inc.). Details about ANOVA and ASCA calculations are reported in the Supplementary Materials.</p></sec></sec><sec id="Sec7"><title>Results and discussion</title><p>The untargeted GC-TOF-MS metabolomics data included 279 variables that covered metabolite classes such as organic acids, carbohydrates, amino acids, and fatty acids. A total of 164 out of 279 variables were identified at level 2, according to the Metabolomics Standard Initiative (MSI) (Sumner et al. <xref ref-type="bibr" rid="CR55">2007</xref>). The SCFA data consisted of eight variables including acetic acid, formic acid, propionic acid, isobutyric acid, butyric acid, isovaleric acid, 2-methylbutyric acid, valeric acid and one unknown compound. A total of 44 metadata variables were used in this study. Table S1 in Supplementary Material contains a list of all the variables investigated in this study. The final size of the data was 105 samples and 331 variables.</p><p>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Major discriminant variables reflecting BG treatment effects. The arrow indicates which of the two treatments showed an increase in relative levels of a marker variable</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="3">Untargeted GC-TOF-MS variables</th></tr><tr><th align="left">Metabolite/Variable</th><th align="left">Comparison</th><th align="left">P-value</th></tr></thead><tbody><tr><td align="left" colspan="3">Males</td></tr><tr><td align="left">&#x000a0;Unknown 16</td><td align="left">Control vs. Oat &#x02191;</td><td align="left">0.00550</td></tr><tr><td align="left">&#x000a0;1,2-Propanediol-2TMS</td><td align="left">Control &#x02191; vs. BG</td><td align="left">0.0399</td></tr><tr><td align="left">&#x000a0;d-2-Aminobutyric acid-2-TMS</td><td align="left">Control vs. BG &#x02191;</td><td align="left">0.0225</td></tr><tr><td align="left">&#x000a0;Palmitoleic acid-1TMS</td><td align="left">Control vs. BG &#x02191;</td><td align="left">0.0335</td></tr><tr><td align="left">&#x000a0;Linoleic acid-1TMS</td><td align="left">Control &#x02191; vs. BG</td><td align="left">0.0381</td></tr><tr><td align="left">&#x000a0;11-Eicosenoic acid-1TMS</td><td align="left">Control &#x02191; vs. BG</td><td align="left">0.0314</td></tr><tr><td align="left">&#x000a0;Urea-2TMS</td><td align="left">Barley &#x02191; vs. Oat</td><td align="left">0.0465</td></tr><tr><td align="left">&#x000a0;Unknown 59 (sugar)</td><td align="left">Barley vs. Oat &#x02191;</td><td align="left">0.0213</td></tr><tr><td align="left" colspan="3">Females</td></tr><tr><td align="left">&#x000a0;Enterolactone</td><td align="left">Control &#x02191; vs. Oat</td><td align="left">0.0179</td></tr><tr><td align="left">&#x000a0;Unknown 82</td><td align="left">Control &#x02191; vs. Oat</td><td align="left">0.0132</td></tr><tr><td align="left">&#x000a0;Hexamethyldisilthiane</td><td align="left">Control &#x02191; vs. BG</td><td align="left">0.00555</td></tr><tr><td align="left">&#x000a0;Ethylene glycol-2TMS</td><td align="left">Control vs. BG &#x02191;</td><td align="left">0.0491</td></tr><tr><td align="left">&#x000a0;Mannose, 6-deoxy-2,3,4,5-tetrakis-<italic>O</italic>-(trimethylsilyl)-, L-</td><td align="left">Control &#x02191; vs. BG</td><td align="left">0.0123</td></tr><tr><td align="left">&#x000a0;Unknown 72</td><td align="left">Control &#x02191; vs. BG</td><td align="left">0.0236</td></tr><tr><td align="left">&#x000a0;4-<italic>O</italic>-&#x003b2;-Galactopyranosyl-<sc>d</sc>-mannopyranose, octakis(trimethylsilyl) ether (isomer 2)</td><td align="left">Control &#x02191; vs. BG</td><td align="left">0.0058</td></tr><tr><td align="left">&#x000a0;Unknown 79</td><td align="left">Control &#x02191; vs. BG</td><td align="left">0.0373</td></tr><tr><td align="left">&#x000a0;Enterolactone</td><td align="left">Control &#x02191; vs. BG</td><td align="left">0.0028</td></tr><tr><td align="left">&#x000a0;Tetracosanoic acid-1TMS</td><td align="left">Control &#x02191; vs. BG</td><td align="left">0.0434</td></tr><tr><td align="left">&#x000a0;Unknown 82</td><td align="left">Control &#x02191; vs. BG</td><td align="left">0.0009</td></tr><tr><td align="left">&#x000a0;Tocopherol-&#x003b3;-tms-derivative</td><td align="left">Control &#x02191; vs. BG</td><td align="left">0.0024</td></tr><tr><td align="left">&#x000a0;Unknown 89</td><td align="left">Control &#x02191; vs. BG</td><td align="left">0.0042</td></tr><tr><td align="left">&#x000a0;Glycolic acid-2TMS</td><td align="left">Barley &#x02191; vs. Oat</td><td align="left">0.0077</td></tr><tr><td align="left">&#x000a0;3-Hydroxybutanoic acid-2TMS</td><td align="left">Barley &#x02191; vs. Oat</td><td align="left">0.0345</td></tr><tr><td align="left">&#x000a0;Unknown 7</td><td align="left">Barley &#x02191; vs. Oat</td><td align="left">0.0160</td></tr><tr><td align="left">&#x000a0;Unknown 37</td><td align="left">Barley &#x02191; vs. Oat</td><td align="left">0.0398</td></tr><tr><td align="left">&#x000a0;Myo-Inositol-5TMS, bis(trimethylsilyl) phosphate</td><td align="left">Barley &#x02191; vs. Oat</td><td align="left">0.0250</td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="3">SCFA and metadata variables</th></tr></thead><tbody><tr><td align="left" colspan="3">Males</td></tr><tr><td align="left">&#x000a0;Formic Acid</td><td align="left">Barley &#x02191; vs. Oat</td><td align="left">0.0099</td></tr><tr><td align="left">&#x000a0;Total plasma SCFA</td><td align="left">Barley &#x02191; vs. Oat</td><td align="left">0.0324</td></tr><tr><td align="left">&#x000a0;Subjective fullness</td><td align="left">Barley vs. Oat &#x02191;</td><td align="left">0.0172</td></tr><tr><td align="left" colspan="3">Females</td></tr><tr><td align="left">&#x000a0;Isobutyrate</td><td align="left">Barley &#x02191; vs. Oat</td><td align="left">0.0108</td></tr><tr><td align="left">&#x000a0;IsoValerate</td><td align="left">Barley &#x02191; vs. Oat</td><td align="left">0.0290</td></tr><tr><td align="left">&#x000a0;2MethylButyrate</td><td align="left">Barley &#x02191; vs. Oat</td><td align="left">0.0205</td></tr></tbody></table></table-wrap>
</p><p>Initial PCA analysis of the <bold>&#x00394;X</bold> and <bold>X</bold>
<sub><bold>T1</bold></sub>, using all three datasets separately as well as combined dataset, showed no clear separation of individuals based on the BG treatment, but individual and gender related variations were more pronounced (Fig.&#x000a0;S1 in Supplementary Material). In order to study the effects related to the study design, three main effects, <bold>TR, GN</bold> and <bold>IN</bold>, and their two-factor interaction effects were studied by ASCA using the <bold>&#x00394;X</bold> and <bold>X</bold>
<sub><bold>T1</bold></sub> datasets. Variations derived from the study design were decomposed as following:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{X = X}}_{{{\mathbf{MEAN}}}} {\mathbf{ + X}}_{{{\mathbf{IN}}}} {\mathbf{ + X}}_{{{\mathbf{TR}}}} {\mathbf{ + X}}_{{{\mathbf{RESIDUALS}}}}$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mi mathvariant="bold">MEAN</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mi mathvariant="bold">IN</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mi mathvariant="bold">TR</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mi mathvariant="bold">RESIDUALS</mml:mi></mml:msub></mml:mrow></mml:math><graphic xlink:href="11306_2017_1247_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>
<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{X = X}}_{{{\mathbf{MEAN}}}} {\mathbf{ + X}}_{{{\mathbf{TR}}}} {\mathbf{ + X}}_{{{\mathbf{GN}}}} {\mathbf{ + X}}_{{{\mathbf{TR \times GN}}}} {\mathbf{ + X}}_{{{\mathbf{RESIDUALS}}}}$$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">X</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mi mathvariant="bold">MEAN</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mi mathvariant="bold">TR</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mi mathvariant="bold">GN</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="bold">TR</mml:mi><mml:mo>&#x000d7;</mml:mo><mml:mi mathvariant="bold">GN</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mo>+</mml:mo><mml:mi mathvariant="bold">X</mml:mi></mml:mrow><mml:mi mathvariant="bold">RESIDUALS</mml:mi></mml:msub></mml:mrow></mml:math><graphic xlink:href="11306_2017_1247_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>where <bold>X</bold> stands for either <bold>&#x00394;X</bold> or <bold>X</bold>
<sub><bold>T1</bold></sub>.</p><p>Due to the fact that <bold>GN</bold> is nested within <bold>IN</bold>, it is impossible to evaluate all three factors simultaneously. Moreover, this study design does not allow to estimate <bold>IN</bold> and <bold>TR</bold> interaction term due to the consumption of degrees of freedom (Eq.&#x000a0;<xref rid="Equ1" ref-type="">1</xref>). In order to evaluate <bold>TR</bold> and <bold>GN</bold> interaction terms using ASCA, the final dataset was balanced by removing four individuals where measurement time points were missing, which left 36 samples for the analysis. Both, <bold>&#x00394;X</bold> and <bold>X</bold>
<sub><bold>T1</bold></sub> datasets were investigated using Equations <xref rid="Equ1" ref-type="">1</xref> and <xref rid="Equ2" ref-type="">2</xref> using the combined data from GC-TOF-MS, SCFA and metadata (Tables&#x000a0;S2 and S3 in Supplementary Material).</p><p>Using the combined dataset, <bold>X</bold>
<sub><bold>T1</bold></sub> revealed significant (P&#x02009;=&#x02009;1.8E&#x02212;13) <bold>IN</bold> effect which explains 27.7% variation, while <bold>TR</bold> effect was not significant (P&#x02009;=&#x02009;0.73) and explained 6.6% variation. The <bold>IN</bold> effect was no longer significant (P&#x02009;=&#x02009;0.64, 17.9% variation) when combined data was evaluated using <bold>&#x00394;X</bold>. Likewise, <bold>TR</bold> effect was also not significant (P&#x02009;=&#x02009;0.78, 7.9% variation). A similar picture emerged when GC-TOF-MS data was evaluated for the <bold>IN</bold> and <bold>TR</bold>, using both <bold>&#x00394;X</bold> and <bold>X</bold>
<sub><bold>T1</bold></sub> datasets. The SCFA data depicted large <bold>IN</bold> effect from <bold>X</bold>
<sub><bold>T1</bold></sub> (P&#x02009;=&#x02009;1.49E&#x02212;10) explaining 56.2% variation, though the <bold>TR</bold> effect remained not significant (P&#x02009;=&#x02009;0.16, 5.3% variation). However, the <bold>&#x00394;X</bold> of the SCFA data showed that the <bold>TR</bold> effect was on the border of being significant (P&#x02009;=&#x02009;0.052) and explained the largest <bold>TR</bold> variation, 12.9%, when compared to the other datasets. Similar to the SCFA data, the metadata showed large <bold>IN</bold> effect (P&#x02009;=&#x02009;1.0E&#x02212;9, 44.9% variation) from <bold>X</bold>
<sub><bold>T1</bold></sub> and a nearly significant <bold>TR</bold> effect (P&#x02009;=&#x02009;0.063, 10.5% variation) when evaluated by <bold>&#x00394;X</bold>.</p><p>The <bold>GN</bold> effect and its interaction with <bold>TR</bold> were evaluated according to the Eq.&#x000a0;<xref rid="Equ2" ref-type="">2</xref> using both the <bold>&#x00394;X</bold> and <bold>X</bold>
<sub><bold>T1</bold></sub> datasets. The <bold>GN</bold> effect was significant from <bold>X</bold>
<sub><bold>T1</bold></sub> in all datasets including GC-TOF-MS (P&#x02009;=&#x02009;0.02), SCFA (P&#x02009;=&#x02009;2.47E-4), metadata (P&#x02009;=&#x02009;3.05E&#x02212;7) and the combined dataset (P&#x02009;=&#x02009;1.99E-4). The explained variances were 5.2, 22.1, 14.9, 6.9%, respectively. The interaction term between <bold>GN</bold> and <bold>TR</bold> was not found to be significant in any cases.</p><p>The initial PCA and ASCA analysis suggests that the major variation on human fecal metabolome as well as on metadata were largely related to inter-individual and gender differences. However, a weak effect of BG treatment was observed in SCFA and metadata using <bold>&#x00394;X</bold>. The sections below explore the <bold>GN</bold> effect in detail using <bold>X</bold>
<sub><bold>T1</bold></sub> and the <bold>TR</bold> effect using <bold>&#x00394;X</bold> for the combined dataset. The effects will be further discussed on metabolite levels identified as being discriminant markers between males and females as well as for the different BG treatments.</p><sec id="Sec8"><title>Gender effect</title><p>A PCA model of the combined dataset using <bold>X</bold>
<sub><bold>T1</bold></sub>, showed a gender related clustering amongst the participants (Fig.&#x000a0;S1 in Supplementary Material). This effect became even more pronounced on the PCA model developed on the gender effect separated matrix, <bold>X</bold>
<sub><bold>GN</bold></sub> Eq.&#x000a0;(<xref rid="Equ2" ref-type="">2</xref>) using ASCA (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).</p><p>
<fig id="Fig2"><label>Fig. 2</label><caption><p>Bi-plot showing PC1 vs. PC3 scores and loadings of the PCA model calculated on the gender effect separated data matrix, <bold>X</bold>
<sub><bold>GN</bold></sub>. On the left, the colors represent the gender classes, whilst on the right, the same plot is <italic>colored</italic> according to the treatment. PC3 was chosen instead of PC2 due to the fact that it showed better separation between the gender classes</p></caption><graphic xlink:href="11306_2017_1247_Fig2_HTML" id="d29e1403"/></fig>
</p><p>In order to find the most discriminative variables separating men from women, PLS-DA based variable selection was performed on the gender separated matrix, <bold>X</bold>
<sub><bold>GN</bold></sub>, as described previously (Khakimov et al. <xref ref-type="bibr" rid="CR34">2016</xref>). PLS-DA models were validated using a double-check validation scheme as described in the literature (Szymanska et al. <xref ref-type="bibr" rid="CR56">2012</xref>). The final PLS-DA model, which included one principal component, possessed a high classification power with approximately 19% misclassification rate using independent test set samples (30% of total samples). Identified metabolite markers from the PLS-DA based variable selection were further tested using a one-way ANOVA. Five out of 7 variables selected from the multivariate PLS-DA approach were also found to be significant in a univariate one-way ANOVA and they include diastolic pressure, body weight, energy intake, total ghrelin and ad libitum lunch (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).</p><p>One of the gender metabolite markers was ghrelin which was higher in females compared to males. Ghrelin is a peptide hormone formed by 28 amino-acids and it is secreted by endocrine cells in the stomach (Abu-Fahra et al. <xref ref-type="bibr" rid="CR1">2014</xref>). In a study on 24 non-diabetic adults focused on the effect of different nutrient loads (glucose, protein and lipids) upon ghrelin levels, Greenman et al. (<xref ref-type="bibr" rid="CR19">2004</xref>) found that ghrelin levels were significantly higher in females both at fasting state and after the glucose and lipid intervention. Gender-related difference in total plasma ghrelin was also reported by Makovey et al. (<xref ref-type="bibr" rid="CR43">2007</xref>), who measured it in opposite-gender twins, and by Abu-Fahra et al. (<xref ref-type="bibr" rid="CR1">2014</xref>), who investigated plasma ghrelin levels of 359 residents of Kuwait. The fact that there is significant difference in ghrelin levels between the two genders suggests that this factor could have an impact on the response to the intervention. In fact, ghrelin has been shown to stimulate appetite and release of cortisol, decrease energy metabolism and promote adipogenesis (Makovey et al. <xref ref-type="bibr" rid="CR43">2007</xref>). The levels of ghrelin in plasma are increased in fasted states and are lowered after meals (Makovey et al. <xref ref-type="bibr" rid="CR43">2007</xref>). It is thus likely that ghrelin has an influence on metabolism and appetite in humans and therefore could cause different behavior and responses to the selected treatment between males and females. Indeed, the administration of ghrelin to mice and rats has been shown to cause an increased food intake and weight gain (Tsch&#x000f6;p et al. <xref ref-type="bibr" rid="CR58">2000</xref>).</p></sec><sec id="Sec9"><title>Treatment-related effects</title><p>The initial hypothesis of this study was that the three structurally different BG may exert slightly varying hypocholesterolemic effects in humans. The previous study showed that oat BG had a great functional potential, with a greater decrease in fasting triacylglycerol, which might be due to physicochemical properties such as higher viscosity and solubility (Ibr&#x000fc;gger et al. <xref ref-type="bibr" rid="CR24">2013</xref>). The consumption of oat and barley derived BG by young healthy adults showed no clear treatment-related effect when the plasma metabolome was investigated by NMR spectroscopy (Mikkelsen et al. <xref ref-type="bibr" rid="CR47">2014</xref>). However, the study revealed the presence of subject-dependent lipoprotein plasma profiles and variations due to gender, BMI and diet.</p><p>In this study, ASCA and PCA analysis performed on the <bold>&#x00394;X</bold> showed a partial discrimination of the treatments, oat BG subjects were more different than others (data not shown). However, PCA of <bold>&#x00394;X</bold> could not capture an effect of all BG groups. This may be due to a small treatment effect compared to the large inter-individual and gender variation. In order to reduce complexity, three different combinations: oat BG vs. control, oat BG vs. barley BG, and control vs. all types of BG, were studied in detail.</p><p>A previous study (Frank et al. <xref ref-type="bibr" rid="CR18">2004</xref>) showed that the intake of oat BG lowered cholesterol level in females more than in males, thus suggesting a modulation of the effect of BG intake depending on gender. In this study the effects of BG treatments were not always consistent for both genders (data not shown) and the effects were often more clear when one gender was studied at a time. Below we will describe effects of treatments separately for each gender.</p><sec id="Sec10"><title>Control vs. oat</title><p>The effect of the oat BG intake was mostly pronounced among males, where one particular variable, unknown 16, was able to discriminate oat BG group from a control group (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Few other variables were also consistently detected being markers for oat BG group, including females. Two metabolites were mostly responsible for this discrimination and they both decrease during the oat treatment. One of them is enterolactone. Further results are reported in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and the discussion is found in the Supplementary Material.</p><p>
<fig id="Fig3"><label>Fig. 3</label><caption><p>Relative concentrations of major variables found to be discriminative for treatments, using <bold>&#x00394;X</bold> data: <bold>a</bold> unknown 16 for control vs. oat in males; <bold>b</bold> unknown 82 for control vs. BG in females; <bold>c</bold> GABA for control vs. BG in males and <bold>d</bold> subjective fullness for barley vs. oat in males</p></caption><graphic xlink:href="11306_2017_1247_Fig3_HTML" id="d29e1507"/></fig>
</p></sec><sec id="Sec11"><title>Control vs. BG</title><p>Evaluation of all types of BG treatment groups simultaneously against the control group using PLS-DA and ANOVA revealed 11 variables that were identified as markers for BG treatments in females. Most of the discriminative metabolites decreased during the BG treatment including mannose and unknown 82 (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). The decrease of sugars could be ascribed to the delay and decrease in starch metabolism and carbohydrate absorption due to the action of BG (Andrade et al. <xref ref-type="bibr" rid="CR2">2016</xref>).</p><p>In males, five variables were able to discriminate between the two groups, and among these gamma-amino-butyrate (GABA) was the most powerful marker which was increased in the BG groups (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). However, a similar intervention study involving BG intake derived from a whole grain barley pasta have shown contradicting results where GABA level was decreased as a function of BG intake among elderly males and females (De Angelis et al. <xref ref-type="bibr" rid="CR12">2015</xref>). Palmitoleic acid level was elevated in the BG groups which is in agreement with a previous study involving oat bran consumption (Gu et al. <xref ref-type="bibr" rid="CR20">2015</xref>). Moreover, we found that lipids including linoleic acid, 11-eicosenoic acid and 1,2-propanediol levels were decreased in the BG groups.</p></sec><sec id="Sec12"><title>Barley vs. Oat</title><p>A total of eight variables were found to be different between female subjects who received either barley BG or oat BG. PLS-DA and ANOVA revealed that the levels of glycolic acid, 3-hydroxybutanoic acid and myo-inositol, together with the SCFA including isobutyric acid, isovaleric acid and 2-methylbutyric acid were higher in individuals receiving barley BG (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). A high inter-correlation of some SCFA suggests presence of a strong relation in their metabolism which is high likely to be influenced by the BG consumption (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). In fact, the anaerobic intestinal microbiota ferment BG, after these are digested into glucopyranosides, into SCFA (Topping and Clifton <xref ref-type="bibr" rid="CR57">2001</xref>). Likewise, in this study, De Angelis et al. (<xref ref-type="bibr" rid="CR12">2015</xref>) also found increased level of isobutyric acid in fecal samples as a function of BG intake through a pasta meal in a 2-month intervention study involving 26 healthy subjects. In addition, Nilsson et al. (<xref ref-type="bibr" rid="CR49">2008</xref>) found increased fecal concentrations of isobutyrate and isovalerate after a dietary supplementation of BG enriched oat bran in 25 young healthy individuals.</p><p>
<fig id="Fig4"><label>Fig. 4</label><caption><p>Correlation between 2-methyl butyrate and isobutyrate using &#x00394;X data, differentiating the barley BG and oat BG groups among female subjects</p></caption><graphic xlink:href="11306_2017_1247_Fig4_HTML" id="d29e1561"/></fig>
</p><p>In males, formic acid, total plasma SCFA and urea were increased during barley BG treatment, whilst the concentration of unknown 59, tentatively identified as sugar metabolite, was decreased. In agreement with this study, Nilsson et al. (<xref ref-type="bibr" rid="CR49">2008</xref>) reported a decreased level of fecal formic acid after 4 weeks of an oat bran intervention involving 25 young healthy adults. A decrease in formic acid suggests that the level of this metabolite is largely reduced due to the barley BG intake, since it is continuously synthesized in colon during a microbial fermentation. The subjective fullness was found to be higher as a result of the oat BG intervention which is in accordance with previously published studies (Juvonen et al. <xref ref-type="bibr" rid="CR28">2009</xref>; Vitaglione et al. <xref ref-type="bibr" rid="CR59">2009</xref>) and might be related to the generally higher solubility and viscosity of oat BG (Juvonen et al. <xref ref-type="bibr" rid="CR28">2009</xref>). The fact that subjective fullness appears as significant only for males, may be due to the different ghrelin values found between the two genders (see Sect.&#x000a0;3.1), as this hormone is directly related to food intake.</p><p>A previous study showed that oat BG improved satiety in both females and males and the actual food intake of a second meal after a BG enriched meal was lower in males (Beck et al. <xref ref-type="bibr" rid="CR5">2009a</xref>). Conflicting results, though, are also present in literature: a review by Cloetens and colleagues presents 31 studies on the effects of BG intake and among these 8 showed no significant results in any measured parameters, whilst many others only had partial results (Cloetens et al. <xref ref-type="bibr" rid="CR01">2012</xref>). Therefore, a debate around the weight control effect of BG enriched meals are still present since the effect can depend on the food item into which BG are added, the type of BG (Jenkins et al. <xref ref-type="bibr" rid="CR27">2002</xref>; Bjorklund et al. <xref ref-type="bibr" rid="CR7">2005</xref>) and maybe even this effect can be different in different subject groups.</p></sec></sec><sec id="Sec13"><title>Main treatment related results</title><p>This study has revealed relatively weak effects of BG intake when compared against the control group receiving a non-fiber glucagel, although a stronger discrimination was found when the barley BG treatment was compared with the oat BG treatment. Moreover, the SCFA were found to be modulated differently by oat and barley BG which in turn indicate that different BG can alter the anaerobic bacterial fermentation and result in different metabolic profiles. SCFA are directly correlated to BG, since they originate from their metabolism by the gut microbiota (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). Formate, which was found to be higher in males after the barley BG intervention, is in fact one of the first product originating from BG gut degradation, deriving from the metabolism of pyruvate. The other SCFA found in different levels between oat and barley BG treatments, derive from later stages of pyruvate metabolism and transformation of butyrate.</p><p>
<fig id="Fig5"><label>Fig. 5</label><caption><p>Metabolic destiny of BG through fermentation by the gut microbiota. Glucopyranosides (Glc<italic>p</italic>) are metabolized into pyruvate, which in turn can be metabolized into to various other metabolites including SCFA. Metabolites in <italic>green</italic> are intermediate compounds, whilst metabolites in dark red are end products</p></caption><graphic xlink:href="11306_2017_1247_Fig5_HTML" id="d29e1615"/></fig>
</p><p>The employed oat BG extract was more soluble than the barley counterparts and had a higher viscosity. These two factors of the oat BG makes it more effective towards the improvement of the wellbeing (Cloetens et al. <xref ref-type="bibr" rid="CR01">2012</xref>). However, only a weak effect was observed between oat and control treatments. The experienced weak effects can be related to different reasons. The investigated subjects were all young healthy adults with relatively fast metabolism and with no specific cholesterol or diet-related issues and this might be the reason why the intervention did not show specific effects in cholesterolaemia and related anthropometric and blood parameters. In fact, it has been observed before that the cholesterol-lowering property of BG was more pronounced in subjects with initially higher cholesterolaemia (&#x000d6;nning et al. <xref ref-type="bibr" rid="CR50">1999</xref>; Frank et al. <xref ref-type="bibr" rid="CR18">2004</xref>).</p><p>In addition, the number of subjects involved in this study was relatively small and a large part of the data variation was related to the gender and inter-individual differences. Most importantly, the dietary intervention was performed by the addition of only the recommended daily dose of BG and only for a short period of time (3 weeks). Thus, in a group of healthy young people this may not be sufficient to show strong metabolic effects. This is supported by the fact that Nilsson et al. (<xref ref-type="bibr" rid="CR49">2008</xref>) observed an increase in fecal SCFA only after 8 weeks of intervention on a healthy cohort. They hypothesized that the colonic microbiota is more stable in healthy subjects, thus a change in its composition requires more time. Moreover, they experience a decreased in carboxylic acid concentrations after 12 weeks of intervention, possibly due to an adaptation of the microbiota.</p><p>The relative low dose of BG, 3.3&#x000a0;g/day, corresponding to the FDA and EFSA health claim, might also influence the results. In fact, most of the interventions employed higher doses of BG (M&#x000e4;kel&#x000e4;inen et al. <xref ref-type="bibr" rid="CR42">2007</xref>; Beck et al. <xref ref-type="bibr" rid="CR4">2009b</xref>; Lyly et al. <xref ref-type="bibr" rid="CR41">2010</xref>), especially when added as a supplement to other foods. However, even at higher doses, some studies have showed no effect of BG (Davy et al. <xref ref-type="bibr" rid="CR11">2002</xref>; Keogh et al. <xref ref-type="bibr" rid="CR31">2003</xref>; Beck et al. <xref ref-type="bibr" rid="CR5">2010</xref>). Major metabolic effects due to the BG intake in this study were more clearly manifested in some individuals, which indicate that the effect of BG might have a rather personalized function. Therefore the <bold>IN</bold> effect was found to be the most dominating. For all these reasons, further studies with much larger cohorts are necessary to better investigate the fecal metabolome variation after BG intervention. This should also allow to better estimate phenotypic and individual responses to BG supplements. In addition, a higher dose of BG and/or hypercholesterolemic subjects might be necessary to evaluate effects and the plausible differences between the structurally different BG.</p><p>Moreover, the complexity of the metabolomics data and the fact that only a relatively scarce literature exists, especially for human studies and related to specific dietary intervention, made it difficult to assign many metabolites with confidence. The intricate interaction between food-derived molecules, digestion and microbiota, generates a complex pattern of fecal metabolites that is not yet clearly defined, especially in interventions where fibers like BG are used and are fermented by the gut microflora. The gut microbiota is a very intricate and its mechanisms and regulations remain largely unknown. Variations in its composition and behavior can depend on many factors including diet and the ethnicity and genetic make-up of the subjects, which can have an influence on its composition (Escobar et al. <xref ref-type="bibr" rid="CR17">2014</xref>; Kwok et al. <xref ref-type="bibr" rid="CR38">2014</xref>; Maukonen and Saarela <xref ref-type="bibr" rid="CR44">2015</xref>). Therefore, differences between the studied population and the ones considered in previous research might be another reason for the discrepancies found, together with the strong inter-individual effect. Thus, more controlled and carefully design intervention considering all is needed prior to reveal insights into the mode of action and functionality of BG in humans.</p></sec></sec><sec id="Sec14" sec-type="conclusion"><title>Conclusion</title><p>This study demonstrated relatively weak, but consistent metabolic effects in the human fecal metabolome as a function of structurally different BG supplement intake. The weak trends found in this study were well in agreement with the previous findings, which proved only slight tendencies during the intervention and showed that inter-individual and gender-specific effects were more prominent. This underlines the fact that the efficacy of BG interventions depend on factors, such as the length of the intervention, the dose of employed BG supplements, the number of subjects, and perhaps even other phenotypic characteristics. In females, the enterolactone level was decreased when subjects underwent to the BG intake, whilst in males, the GABA level increased after the same treatment. SCFA discriminated oat BG group and barley BG group subjects both for males and females. Barley BG increase specific SCFA levels in both genders, whilst oat BG seems to be more effective in subjective fullness in males. Changes observed in the SCFA profiles as a result of BG intake were in accordance with previously published studies and confirmed the function of in bacterial fermentation in the gut.</p><p>In conclusion, this study represents a step forward in the analytical pipeline towards new research with a larger and more diverse cohort and using a much longer intervention-time with time-dynamic fecal sampling. The chemometrics approaches employed here showed that it is necessary to investigate all the possible effects that may impact data, and to validate observed metabolic effects using independent test set samples. It should be emphasized that the present study represents a relative untargeted fecal metabolomics study and that it is possible that a more targeted approach towards, for example, bile acids and/or cholesterol metabolism can provide additional information.</p></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec15"><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="11306_2017_1247_MOESM1_ESM.doc"><caption><p>Supplementary material 1 (DOC 569 KB)</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (doi:10.1007/s11306-017-1247-2) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This work was supported by the Danish Strategic Research Council/Innovation Foundation Denmark (COUNTERSTRIKE, Grant Number 4105-00015B).</p></ack><notes notes-type="COI-statement"><title>Compliance with Ethical Standards</title><sec id="FPar1"><title>Conflict of interest</title><p>Alessia Trimigno, Bekzod Khakimov, Josue Leonardo Castro Mejia, Mette Skau Mikkelsen, Mette Kristensen, Birthe M&#x000f8;ller Jespersen, S&#x000f8;ren Balling Engelsen declare no conflict of interest.</p></sec><sec id="FPar2"><title>Ethical approval</title><p>The study was carried out at the Department of Nutrition, Exercise, and Sports, Faculty of Science, University of Copenhagen, Denmark, and was approved by the Municipal Ethical Committee of the Capital Region of Denmark in accordance with the Helsinki Declaration (H-4-2009-111). Written informed consents were obtained from all the volunteers.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Farha</surname><given-names>M</given-names></name><name><surname>Dehbi</surname><given-names>M</given-names></name><name><surname>Noronha</surname><given-names>F</given-names></name><name><surname>Tiss</surname><given-names>A</given-names></name><name><surname>Alarouj</surname><given-names>M</given-names></name><name><surname>Behbehani</surname><given-names>K</given-names></name><name><surname>Bennakhi</surname><given-names>A</given-names></name><name><surname>Elkum</surname><given-names>N</given-names></name></person-group><article-title>Gender differences in ghrelin association with cardiometabolic risk factors in arab population</article-title><source>International Journal of Endocrinology</source><year>2014</year><pub-id pub-id-type="pmid">25276131</pub-id></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>EF</given-names></name><name><surname>Lima</surname><given-names>ARV</given-names></name><name><surname>Nunes</surname><given-names>IE</given-names></name><name><surname>Orlando</surname><given-names>DR</given-names></name><name><surname>Gondim</surname><given-names>PN</given-names></name><name><surname>Zangeronimo</surname><given-names>MG</given-names></name><name><surname>Ferrari Alves</surname><given-names>FH</given-names></name><name><surname>Pereira</surname><given-names>LJ</given-names></name></person-group><article-title>Exercise and beta-glucan consumption (<italic>Saccharomyces cerevisiae</italic>) improve the metabolic profile and reduce the atherogenic index in Type 2 diabetic rats (HFD/STZ)</article-title><source>Nutrients</source><year>2016</year><volume>8</volume><issue>12</issue><fpage>792</fpage><pub-id pub-id-type="doi">10.3390/nu8120792</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battilana</surname><given-names>P</given-names></name><name><surname>Ornstein</surname><given-names>K</given-names></name><name><surname>Minehira</surname><given-names>K</given-names></name><name><surname>Schwarz</surname><given-names>JM</given-names></name><name><surname>Acheson</surname><given-names>K</given-names></name><name><surname>Schneiter</surname><given-names>P</given-names></name><name><surname>Burri</surname><given-names>J</given-names></name><name><surname>Jequier</surname><given-names>E</given-names></name><name><surname>Tappy</surname><given-names>L</given-names></name></person-group><article-title>Mechanisms of action of &#x003b2;-glucan in postprandial glucose metabolism in healthy men</article-title><source>European Journal of Clinical Nutrition</source><year>2001</year><volume>55</volume><issue>5</issue><fpage>327</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1601160</pub-id><pub-id pub-id-type="pmid">11378805</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>EJ</given-names></name><name><surname>Tapsell</surname><given-names>LC</given-names></name><name><surname>Batterham</surname><given-names>MJ</given-names></name><name><surname>Tosh</surname><given-names>SM</given-names></name><name><surname>Huang</surname><given-names>XF</given-names></name></person-group><article-title>Increases in peptide Y&#x02013;Y levels following oat &#x003b2;-glucan ingestion are dose-dependent in overweight adults</article-title><source>Nutrition Research</source><year>2009</year><volume>29</volume><issue>10</issue><fpage>705</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2009.09.012</pub-id><pub-id pub-id-type="pmid">19917449</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>EJ</given-names></name><name><surname>Tapsell</surname><given-names>LC</given-names></name><name><surname>Batterham</surname><given-names>MJ</given-names></name><name><surname>Tosh</surname><given-names>SM</given-names></name><name><surname>Huang</surname><given-names>XF</given-names></name></person-group><article-title>Oat &#x003b2;-glucan supplementation does not enhance the effectiveness of an energy-restricted diet in overweight women</article-title><source>British Journal of Nutrition</source><year>2010</year><volume>103</volume><issue>8</issue><fpage>1212</fpage><lpage>1222</lpage><pub-id pub-id-type="pmid">19930764</pub-id></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>EJ</given-names></name><name><surname>Tosh</surname><given-names>SM</given-names></name><name><surname>Batterham</surname><given-names>MJ</given-names></name><name><surname>Tapsell</surname><given-names>LC</given-names></name><name><surname>Huang</surname><given-names>XF</given-names></name></person-group><article-title>Oat &#x003b2;-glucan increases postprandial cholecystokinin levels, decreases insulin response and extends subjective satiety in overweight subjects</article-title><source>Molecular Nutrition &#x00026; Food Research</source><year>2009</year><volume>53</volume><fpage>1343</fpage><lpage>1351</lpage><pub-id pub-id-type="doi">10.1002/mnfr.200800343</pub-id><pub-id pub-id-type="pmid">19753601</pub-id></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bi&#x000f6;rklund</surname><given-names>M</given-names></name><name><surname>van Rees</surname><given-names>A</given-names></name><name><surname>Mensink</surname><given-names>RP</given-names></name><name><surname>&#x000d6;nning</surname><given-names>G</given-names></name></person-group><article-title>Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with &#x003b2;-glucan s from oats and barley: A randomised dose-controlled trial</article-title><source>European Journal of Clinical Nutrition</source><year>2005</year><volume>59</volume><fpage>1272</fpage><lpage>1281</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602240</pub-id><pub-id pub-id-type="pmid">16015250</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourdon</surname><given-names>I</given-names></name><name><surname>Yokoyama</surname><given-names>W</given-names></name><name><surname>Davis</surname><given-names>P</given-names></name><name><surname>Hudson</surname><given-names>C</given-names></name><name><surname>Backus</surname><given-names>R</given-names></name><name><surname>Richter</surname><given-names>D</given-names></name><name><surname>Knuckles</surname><given-names>B</given-names></name><name><surname>Schneeman</surname><given-names>BO</given-names></name></person-group><article-title>Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with &#x003b2;-glucan</article-title><source>American Journal of Clinical Nutrition</source><year>1999</year><volume>69</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">9925123</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Raymond</surname><given-names>K</given-names></name></person-group><article-title>Beta-glucans in the treatment of diabetes and associated cardiovascular risks</article-title><source>Vascular Health and Risk Management</source><year>2008</year><volume>4</volume><issue>6</issue><fpage>1265</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.2147/VHRM.S3803</pub-id><pub-id pub-id-type="pmid">19337540</pub-id></element-citation></ref><ref id="CR01"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cloetens</surname><given-names>L</given-names></name><name><surname>Ulmius</surname><given-names>M</given-names></name><name><surname>Johansson-Persson</surname><given-names>A</given-names></name><name><surname>&#x000c5;kesson</surname><given-names>B</given-names></name><name><surname>&#x000d6;nning</surname><given-names>G</given-names></name></person-group><article-title>Role of dietary beta-glucans in the prevention of the metabolic syndrome</article-title><source>Nutrition Reviews</source><year>2012</year><volume>70</volume><issue>8</issue><fpage>444</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1111/j.1753-4887.2012.00494.x</pub-id><pub-id pub-id-type="pmid">22835138</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daou</surname><given-names>C&#x00026;</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title>Oat Beta-Glucan: Its Role in Health Promotion and Prevention of Diseases</article-title><source>Comprehensive Reviews in Food Science and Food Safety</source><year>2012</year><volume>11</volume><issue>4</issue><fpage>355</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1111/j.1541-4337.2012.00189.x</pub-id></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davy</surname><given-names>BM</given-names></name><name><surname>Melby</surname><given-names>CL</given-names></name><name><surname>Beske</surname><given-names>SD</given-names></name><name><surname>Ho</surname><given-names>RC</given-names></name><name><surname>Davrath</surname><given-names>LR</given-names></name><name><surname>Davy</surname><given-names>KP</given-names></name></person-group><article-title>Oat consumption does not affect resting casual and ambulatory 24-h arterial blood pressure in men with high-normal blood pressure to stage I hypertension</article-title><source>The Journal of Nutrition</source><year>2002</year><volume>132</volume><issue>3</issue><fpage>394</fpage><lpage>398</lpage><pub-id pub-id-type="pmid">11880561</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Angelis</surname><given-names>M</given-names></name><name><surname>Montemurno</surname><given-names>E</given-names></name><name><surname>Vannini</surname><given-names>L</given-names></name><name><surname>Cosola</surname><given-names>C</given-names></name><name><surname>Cavallo</surname><given-names>N</given-names></name><name><surname>Gozzi</surname><given-names>G</given-names></name><name><surname>Maranzano</surname><given-names>V</given-names></name><name><surname>Di Cagno</surname><given-names>R</given-names></name><name><surname>Gobbetti</surname><given-names>M</given-names></name><name><surname>Gesualdo</surname><given-names>L</given-names></name></person-group><article-title>Effect of whole-grain barley on the human fecal microbiota and metabolome</article-title><source>Applied and Environmental Microbiology</source><year>2015</year><volume>81</volume><issue>22</issue><fpage>7945</fpage><lpage>7956</lpage><pub-id pub-id-type="doi">10.1128/AEM.02507-15</pub-id><pub-id pub-id-type="pmid">26386056</pub-id></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delaney</surname><given-names>B</given-names></name><name><surname>Carlson</surname><given-names>T</given-names></name><name><surname>Frazer</surname><given-names>S</given-names></name><name><surname>Zheng</surname><given-names>T</given-names></name><name><surname>Hess</surname><given-names>R</given-names></name><name><surname>Ostergren</surname><given-names>K</given-names></name><name><surname>Kierzek</surname><given-names>K</given-names></name><name><surname>Haworth</surname><given-names>J</given-names></name><name><surname>Knutson</surname><given-names>N</given-names></name><name><surname>Junker</surname><given-names>K</given-names></name><name><surname>Jonker</surname><given-names>D</given-names></name></person-group><article-title>Evaluation of the toxicity of concentrated barley beta-glucan in a 28-day feeding study in Wistar rats</article-title><source>Food Chemistry and Toxicology</source><year>2003</year><volume>41</volume><issue>4</issue><fpage>477</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1016/S0278-6915(02)00298-3</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Department of Health and Human Services, Food and Drug Administration</collab></person-group><article-title>21 CFR Part 101</article-title><source>Food Labelling: Health Claims, Oats and Coronary Heart Disease, Federal Register</source><year>1997</year><volume>62</volume><issue>15</issue><fpage>18</fpage></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)</collab></person-group><article-title>Scientific Opinion on the substantiation of a health claim related to oat beta-glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 192472006</article-title><source>EFSA Journal 2010</source><year>2010</year><volume>8</volume><issue>12</issue><fpage>1885</fpage><lpage>1899</lpage></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escobar</surname><given-names>JS</given-names></name><name><surname>Klotz</surname><given-names>B</given-names></name><name><surname>Valdez</surname><given-names>BE</given-names></name><name><surname>Agudelo</surname><given-names>GM</given-names></name></person-group><article-title>The gut microbiota of Colombians differs from that of Americans, Europeans and Asians</article-title><source>BMC Microbiology</source><year>2014</year><volume>14</volume><issue>1</issue><fpage>1</fpage><pub-id pub-id-type="doi">10.1186/s12866-014-0311-6</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>J</given-names></name><name><surname>Sundberg</surname><given-names>B</given-names></name><name><surname>Kamal-Eldin</surname><given-names>A</given-names></name><name><surname>Vessby</surname><given-names>B</given-names></name><name><surname>&#x000c5;man</surname><given-names>P</given-names></name></person-group><article-title>Yeast-leavened oat breads with high or low molecular weight &#x003b2;-glucan do not differ in their effects on blood concentrations of lipids, insulin, or glucose in humans</article-title><source>Journal of Nutrition</source><year>2004</year><volume>134</volume><fpage>1384</fpage><lpage>1388</lpage><pub-id pub-id-type="pmid">15173400</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenman</surname><given-names>Y</given-names></name><name><surname>Golani</surname><given-names>N</given-names></name><name><surname>Gilad</surname><given-names>S</given-names></name><name><surname>Yaron</surname><given-names>M</given-names></name><name><surname>Limor</surname><given-names>R</given-names></name><name><surname>Stern</surname><given-names>N</given-names></name></person-group><article-title>Ghrelin secretion is modulated in a nutrient-and gender-specific manner</article-title><source>Clinical Endocrinology</source><year>2004</year><volume>60</volume><issue>3</issue><fpage>382</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2265.2004.01993.x</pub-id><pub-id pub-id-type="pmid">15009005</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Jing</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>GC&#x02013;TOF-MS-based serum metabolomic investigations of naked oat bran supplementation in high-fat-diet-induced dyslipidemic rats</article-title><source>The Journal of Nutritional Biochemistry</source><year>2015</year><volume>26</volume><issue>12</issue><fpage>1509</fpage><lpage>1519</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2015.07.019</pub-id><pub-id pub-id-type="pmid">26388495</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrera</surname><given-names>MP</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Vasanthan</surname><given-names>T</given-names></name><name><surname>Temelli</surname><given-names>F</given-names></name><name><surname>Henderson</surname><given-names>K</given-names></name></person-group><article-title>&#x003b2;-Glucan content, viscosity, and solubility of Canadian grown oat as influenced by cultivar and growing location</article-title><source>Canadian Journal of Plant Science</source><year>2016</year><volume>96</volume><issue>2</issue><fpage>183</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1139/cjps-2014-0440</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotelling</surname><given-names>H</given-names></name></person-group><article-title>Analysis of a complex of statistical variables into principal components</article-title><source>Journal of Educational Psychology</source><year>1933</year><volume>24</volume><issue>6</issue><fpage>417</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1037/h0071325</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>SA</given-names></name><name><surname>Shewry</surname><given-names>PR</given-names></name><name><surname>Gibson</surname><given-names>GR</given-names></name><name><surname>McCleary</surname><given-names>BV</given-names></name><name><surname>Rastall</surname><given-names>RA</given-names></name></person-group><article-title>In vitro fermentation of oat and barley derived &#x003b2;&#x02013;glucans by human faecal microbiota</article-title><source>FEMS Microbiology Ecology</source><year>2008</year><volume>64</volume><issue>3</issue><fpage>482</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6941.2008.00478.x</pub-id><pub-id pub-id-type="pmid">18430007</pub-id></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibr&#x000fc;gger</surname><given-names>S</given-names></name><name><surname>Kristensen</surname><given-names>M</given-names></name><name><surname>Poulsen</surname><given-names>MW</given-names></name><name><surname>Mikkelsen</surname><given-names>MS</given-names></name><name><surname>Ejsing</surname><given-names>J</given-names></name><name><surname>Jespersen</surname><given-names>BM</given-names></name><name><surname>Dragsted</surname><given-names>LO</given-names></name><name><surname>Engelsen</surname><given-names>SB</given-names></name><name><surname>B&#x000fc;gel</surname><given-names>S</given-names></name></person-group><article-title>Extracted oat and barley beta-glucans do not affect cholesterol metabolism in young healthy adults</article-title><source>Journal of Nutrition</source><year>2013</year><volume>143</volume><issue>10</issue><fpage>1579</fpage><lpage>1985</lpage><pub-id pub-id-type="doi">10.3945/jn.112.173054</pub-id><pub-id pub-id-type="pmid">23946347</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izydorczyk</surname><given-names>MS</given-names></name><name><surname>Biliaderis</surname><given-names>CG</given-names></name></person-group><article-title>Structural and functional aspects of cereal arabinoxylans and &#x003b2;-glucans</article-title><source>Developments in Food Science</source><year>2000</year><volume>41</volume><fpage>361</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1016/S0167-4501(00)80016-3</pub-id></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>AL</given-names></name><name><surname>Jenkins</surname><given-names>DJA</given-names></name><name><surname>Zdravkovic</surname><given-names>U</given-names></name><name><surname>W&#x000fc;rsch</surname><given-names>P</given-names></name><name><surname>Vuksan</surname><given-names>V</given-names></name></person-group><article-title>Depression of the glycemic index by high levels of &#x003b2;-glucan fiber in two functional foods tested in type 2 diabetes</article-title><source>European Journal of Clinical Nutrition</source><year>2002</year><volume>56</volume><issue>7</issue><fpage>622</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1601367</pub-id><pub-id pub-id-type="pmid">12080401</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juvonen</surname><given-names>KR</given-names></name><name><surname>Purhonen</surname><given-names>AK</given-names></name><name><surname>Salmenkallio-Marttila</surname><given-names>M</given-names></name><name><surname>L&#x000e4;hteenm&#x000e4;ki</surname><given-names>L</given-names></name><name><surname>Laaksonen</surname><given-names>D</given-names></name><name><surname>Herzig</surname><given-names>KH</given-names></name><name><surname>Uusitupa</surname><given-names>MIJ</given-names></name><name><surname>Poutanen</surname><given-names>KS</given-names></name><name><surname>Karhunen</surname><given-names>LJ</given-names></name></person-group><article-title>Viscosity of Oat Bran-Enriched Beverages Influences Gastrointestinal Hormonal Responses in Healthy Humans</article-title><source>The Journal of Nutrition</source><year>2009</year><volume>139</volume><issue>3</issue><fpage>461</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.3945/jn.108.099945</pub-id><pub-id pub-id-type="pmid">19176745</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalra</surname><given-names>S</given-names></name><name><surname>Jood</surname><given-names>S</given-names></name></person-group><article-title>Effect of dietary barley &#x003b2;-glucan on cholesterol and lipoprotein fractions in rat</article-title><source>Journal of Cereal Science</source><year>2000</year><volume>31</volume><fpage>141</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1006/jcrs.1999.0290</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keenan</surname><given-names>JM</given-names></name><name><surname>Pins</surname><given-names>JJ</given-names></name><name><surname>Frazel</surname><given-names>C</given-names></name><name><surname>Moran</surname><given-names>A</given-names></name><name><surname>Turnquist</surname><given-names>L</given-names></name></person-group><article-title>Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: A pilot trial</article-title><source>The Journal of Family Practice</source><year>2002</year><volume>51</volume><issue>4</issue><fpage>369</fpage><pub-id pub-id-type="pmid">11978262</pub-id></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keogh</surname><given-names>GF</given-names></name><name><surname>Cooper</surname><given-names>GJS</given-names></name><name><surname>Mulvey</surname><given-names>TB</given-names></name><name><surname>McArdle</surname><given-names>BH</given-names></name><name><surname>Coles</surname><given-names>GD</given-names></name><name><surname>Monro</surname><given-names>JA</given-names></name><name><surname>Poppitt</surname><given-names>SD</given-names></name></person-group><article-title>Randomized controlled crossover study of the effect of a highly &#x003b2;-glucan enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men</article-title><source>The American Journal of Clinical Nutrition</source><year>2003</year><volume>78</volume><issue>4</issue><fpage>711</fpage><lpage>718</lpage><pub-id pub-id-type="pmid">14522728</pub-id></element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerckhoffs</surname><given-names>D</given-names></name><name><surname>Brouns</surname><given-names>F</given-names></name><name><surname>Hornstra</surname><given-names>G</given-names></name><name><surname>Mensink</surname><given-names>R</given-names></name></person-group><article-title>Effects on the human serum lipoprotein profile of &#x003b2;-glucan, soy proteins and isoflavones, plant sterols and stanols, garlic and tocotrienols</article-title><source>Journal of Nutrition</source><year>2002</year><volume>132</volume><fpage>2492</fpage><lpage>2505</lpage><pub-id pub-id-type="pmid">12221199</pub-id></element-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khakimov</surname><given-names>B</given-names></name><name><surname>Motawia</surname><given-names>MS</given-names></name><name><surname>Bak</surname><given-names>S</given-names></name><name><surname>Engelsen</surname><given-names>SB</given-names></name></person-group><article-title>The use of trimethylsilyl cyanide derivatization for robust and broad-spectrum high-throughput gas chromatography-mass spectrometry based metabolomics</article-title><source>Analytical and Bioanalytical Chemistry</source><year>2013</year><volume>405</volume><issue>28</issue><fpage>9193</fpage><lpage>9205</lpage><pub-id pub-id-type="doi">10.1007/s00216-013-7341-z</pub-id><pub-id pub-id-type="pmid">24091735</pub-id></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khakimov</surname><given-names>B</given-names></name><name><surname>Poulsen</surname><given-names>SK</given-names></name><name><surname>Savorani</surname><given-names>F</given-names></name><name><surname>Acar</surname><given-names>E</given-names></name><name><surname>G&#x000fc;rdeniz</surname><given-names>G</given-names></name><name><surname>Larsen</surname><given-names>TM</given-names></name><name><surname>Astrup</surname><given-names>A</given-names></name><name><surname>Dragsted</surname><given-names>LO</given-names></name><name><surname>Engelsen</surname><given-names>SB</given-names></name></person-group><article-title>New Nordic diet versus average Danish diet: A randomized controlled trial revealed healthy long-term effects of the new Nordic diet by GC-MS blood plasma metabolomics</article-title><source>Journal of Proteome Research</source><year>2016</year><volume>15</volume><issue>6</issue><fpage>1939</fpage><lpage>1954</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.6b00109</pub-id><pub-id pub-id-type="pmid">27146725</pub-id></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kristensen</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>MG</given-names></name><name><surname>Aarestrup</surname><given-names>J</given-names></name><name><surname>Petersen</surname><given-names>KEN</given-names></name><name><surname>S&#x000f8;ndergaard</surname><given-names>L</given-names></name><name><surname>Mikkelsen</surname><given-names>MS</given-names></name><name><surname>Astrup</surname><given-names>A</given-names></name></person-group><article-title>Flaxseed dietary fibers lower cholesterol and increase fecal fat excretion, but magnitude of effect depend on food type</article-title><source>Nutrition &#x00026; Metabolism</source><year>2012</year><volume>9</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1186/1743-7075-9-8</pub-id><pub-id pub-id-type="pmid">22305169</pub-id></element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kristensen</surname><given-names>M</given-names></name><name><surname>Savorani</surname><given-names>F</given-names></name><name><surname>Christensen</surname><given-names>S</given-names></name><name><surname>Engelsen</surname><given-names>SB</given-names></name><name><surname>B&#x000fc;gel</surname><given-names>S</given-names></name><name><surname>Toubro</surname><given-names>S</given-names></name><name><surname>Tetens</surname><given-names>I</given-names></name><name><surname>Astrup</surname><given-names>A</given-names></name></person-group><article-title>Flaxseed dietary fibers suppress postprandial lipemia and appetite sensation in young men</article-title><source>Nutrition, Metabolism, and Cardiovascular Diseases</source><year>2011</year><volume>21</volume><issue>9</issue><fpage>748</fpage><lpage>756</lpage><pub-id pub-id-type="doi">10.1016/j.numecd.2010.02.002</pub-id></element-citation></ref><ref id="CR37"><mixed-citation publication-type="other">Kvist, S. &#x00026; Lawther, J. M. (2011). Soluble dietary fibre from oat and barley grains, method for producing a fraction rich in B-glucan and use of the fraction in foods, pharmaceuticals and cosmetics, US Patent 7910143.</mixed-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwok</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Gesudu</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Qiao</surname><given-names>J</given-names></name><name><surname>Huo</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title>Characterization of fecal microbiota across seven chinese ethnic groups by quantitative polymerase chain reaction</article-title><source>PloS one</source><year>2014</year><volume>9</volume><issue>4</issue><fpage>e93631</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0093631</pub-id><pub-id pub-id-type="pmid">24699404</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>KL</given-names></name><name><surname>Cheung</surname><given-names>PCK</given-names></name></person-group><article-title>Non-digestible long chain beta-glucans as novel prebiotics</article-title><source>Bioactive Carbohydrates and Dietary Fibre</source><year>2013</year><volume>2</volume><issue>1</issue><fpage>45</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.bcdf.2013.09.001</pub-id></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liatis</surname><given-names>D</given-names></name><name><surname>Tsapogas</surname><given-names>P</given-names></name><name><surname>Chala</surname><given-names>E</given-names></name><name><surname>Dimosthenopoulos</surname><given-names>C</given-names></name><name><surname>Kyriakopoulos</surname><given-names>K</given-names></name><name><surname>Kapantais</surname><given-names>E</given-names></name><name><surname>Katsilambros</surname><given-names>N</given-names></name></person-group><article-title>The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type 2 diabetes</article-title><source>Diabetes &#x00026; Metabolism</source><year>2009</year><volume>35</volume><issue>2</issue><fpage>115</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.diabet.2008.09.004</pub-id><pub-id pub-id-type="pmid">19230737</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyly</surname><given-names>M</given-names></name><name><surname>Ohls</surname><given-names>N</given-names></name><name><surname>L&#x000e4;hteenm&#x000e4;ki</surname><given-names>L</given-names></name><name><surname>Salmenkallio-Marttila</surname><given-names>M</given-names></name><name><surname>Liukkonen</surname><given-names>H</given-names></name><name><surname>Karhunen</surname><given-names>L</given-names></name><name><surname>Poutanen</surname><given-names>K</given-names></name></person-group><article-title>The effect of fibre amount, energy level and viscosity of beverages containing oat fibre supplement on perceived satiety</article-title><source>Food and Nutrition Research</source><year>2010</year><volume>54</volume><fpage>2149</fpage><pub-id pub-id-type="doi">10.3402/fnr.v54i0.2149</pub-id></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000e4;kel&#x000e4;inen</surname><given-names>H</given-names></name><name><surname>Anttila</surname><given-names>H</given-names></name><name><surname>Sihvonen</surname><given-names>J</given-names></name><name><surname>Hietanen</surname><given-names>RM</given-names></name><name><surname>Tahvonen</surname><given-names>R</given-names></name><name><surname>Salminen</surname><given-names>E</given-names></name><name><surname>Mikola</surname><given-names>M</given-names></name><name><surname>Sontag-Strohm</surname><given-names>T</given-names></name></person-group><article-title>The effect of &#x003b2;-glucan on the glycemic and insulin index</article-title><source>European Journal of Clinical Nutrition</source><year>2007</year><volume>61</volume><issue>6</issue><fpage>779</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602561</pub-id><pub-id pub-id-type="pmid">17151593</pub-id></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makovey</surname><given-names>J</given-names></name><name><surname>Naganathan</surname><given-names>V</given-names></name><name><surname>Seibel</surname><given-names>M</given-names></name><name><surname>Sambrook</surname><given-names>P</given-names></name></person-group><article-title>Gender differences in plasma ghrelin and its relations to body composition and bone&#x02013;an opposite-sex twin study</article-title><source>Clinical Endocrinology</source><year>2007</year><volume>66</volume><issue>4</issue><fpage>530</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">17371471</pub-id></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maukonen</surname><given-names>J</given-names></name><name><surname>Saarela</surname><given-names>M</given-names></name></person-group><article-title>Human gut microbiota: Does diet matter?</article-title><source>Proceedings of the Nutrition Society</source><year>2015</year><volume>74</volume><issue>1</issue><fpage>23</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1017/S0029665114000688</pub-id><pub-id pub-id-type="pmid">25156389</pub-id></element-citation></ref><ref id="CR45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazur</surname><given-names>WM</given-names></name><name><surname>Uehara</surname><given-names>M</given-names></name><name><surname>W&#x000e4;h&#x000e4;l&#x000e4;</surname><given-names>K</given-names></name><name><surname>Adlercreutz</surname><given-names>H</given-names></name></person-group><article-title>Phyto-oestrogen content of berries, and plasma concentrationsand urinary excretion of enterolactone after asingle strawberry-meal in human subjects</article-title><source>British journal of nutrition</source><year>2000</year><volume>83</volume><issue>04</issue><fpage>381</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">10858696</pub-id></element-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikkelsen</surname><given-names>MS</given-names></name><name><surname>Jespersen</surname><given-names>BM</given-names></name><name><surname>Larsen</surname><given-names>FM</given-names></name><name><surname>Blennow</surname><given-names>A</given-names></name><name><surname>Engelsen</surname><given-names>SB</given-names></name></person-group><article-title>Molecular structure of large-scale extracted beta-glucan from barley and oat: Identification of a significantly changed block structure in a high beta-glucan barley mutant</article-title><source>Food Chemistry</source><year>2013</year><volume>136</volume><issue>1</issue><fpage>130</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2012.07.097</pub-id><pub-id pub-id-type="pmid">23017403</pub-id></element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikkelsen</surname><given-names>MS</given-names></name><name><surname>Savorani</surname><given-names>F</given-names></name><name><surname>Rasmussen</surname><given-names>MA</given-names></name><name><surname>Jespersen</surname><given-names>BM</given-names></name><name><surname>Kristensen</surname><given-names>M</given-names></name><name><surname>Engelsen</surname><given-names>SB</given-names></name></person-group><article-title>New insights from a &#x003b2;&#x02013;glucan human intervention study using NMR metabolomics</article-title><source>Food Research International</source><year>2014</year><volume>63</volume><fpage>210</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.foodres.2014.01.026</pub-id></element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munck</surname><given-names>L</given-names></name><name><surname>M&#x000f8;ller</surname><given-names>B</given-names></name><name><surname>Jacobsen</surname><given-names>S</given-names></name><name><surname>S&#x000f8;ndergaard</surname><given-names>I</given-names></name></person-group><article-title>Near infrared spectra indicate specific mutant endosperm genes and reveal a new mechanism for substituting starch with (1&#x02192; 3, 1&#x02192; 4)-&#x003b2;-glucan in barley</article-title><source>Journal of Cereal Science</source><year>2004</year><volume>40</volume><issue>3</issue><fpage>213</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.jcs.2004.07.006</pub-id></element-citation></ref><ref id="CR49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>U</given-names></name><name><surname>Johansson</surname><given-names>M</given-names></name><name><surname>Nilsson</surname><given-names>&#x000c5;</given-names></name><name><surname>Bj&#x000f6;rck</surname><given-names>I</given-names></name><name><surname>Nyman</surname><given-names>M</given-names></name></person-group><article-title>Dietary supplementation with &#x003b2;-glucan enriched oat bran increases faecal concentration of carboxylic acids in healthy subjects</article-title><source>European Journal of Clinical Nutrition</source><year>2008</year><volume>62</volume><issue>8</issue><fpage>978</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602816</pub-id><pub-id pub-id-type="pmid">17522598</pub-id></element-citation></ref><ref id="CR50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000d6;nning</surname><given-names>G</given-names></name><name><surname>Wallmark</surname><given-names>A</given-names></name><name><surname>Persson</surname><given-names>M</given-names></name><name><surname>&#x000c5;kesson</surname><given-names>B</given-names></name><name><surname>Elmst&#x000e5;hl</surname><given-names>S</given-names></name><name><surname>&#x000d6;ste</surname><given-names>R</given-names></name></person-group><article-title>Consumption of oat milk for 5weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia</article-title><source>Annals of Nutrition and Metabolism</source><year>1999</year><volume>43</volume><issue>5</issue><fpage>301</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1159/000012798</pub-id><pub-id pub-id-type="pmid">10749030</pub-id></element-citation></ref><ref id="CR51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Queenan</surname><given-names>KM</given-names></name><name><surname>Stewart</surname><given-names>ML</given-names></name><name><surname>Smith</surname><given-names>KN</given-names></name><name><surname>Thomas</surname><given-names>W</given-names></name><name><surname>Fulcher</surname><given-names>RG</given-names></name><name><surname>Slavin</surname><given-names>JL</given-names></name></person-group><article-title>Concentrated oat &#x003b2;-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial</article-title><source>Nutrition Journal</source><year>2007</year><volume>6</volume><issue>1</issue><fpage>6</fpage><pub-id pub-id-type="doi">10.1186/1475-2891-6-6</pub-id><pub-id pub-id-type="pmid">17386092</pub-id></element-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smilde</surname><given-names>AK</given-names></name><name><surname>Jansen</surname><given-names>JJ</given-names></name><name><surname>Hoefsloot</surname><given-names>HC</given-names></name><name><surname>Lamers</surname><given-names>RJA</given-names></name><name><surname>Van Der Greef</surname><given-names>J</given-names></name><name><surname>Timmerman</surname><given-names>ME</given-names></name></person-group><article-title>ANOVA-simultaneous component analysis (ASCA): A new tool for analyzing designed metabolomics data</article-title><source>Bioinformatics</source><year>2005</year><volume>21</volume><issue>13</issue><fpage>3043</fpage><lpage>3048</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bti476</pub-id><pub-id pub-id-type="pmid">15890747</pub-id></element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St&#x000e5;hle</surname><given-names>L</given-names></name><name><surname>Wold</surname><given-names>S</given-names></name></person-group><article-title>Partial least squares analysis with cross-Validation for the two-class problem A Monte Carlo Study</article-title><source>Journal of Chemometrics</source><year>1987</year><volume>1</volume><issue>3</issue><fpage>185</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1002/cem.1180010306</pub-id></element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>P</given-names></name><name><surname>Arendt</surname><given-names>E</given-names></name><name><surname>Gallagher</surname><given-names>E</given-names></name></person-group><article-title>The increasing use of barley and barley by-products in the production of healthier baked goods</article-title><source>Trends in Food Science &#x00026; Technology</source><year>2013</year><volume>29</volume><issue>2</issue><fpage>124</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/j.tifs.2012.10.005</pub-id></element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumner</surname><given-names>LW</given-names></name><name><surname>Amberg</surname><given-names>A</given-names></name><name><surname>Barrett</surname><given-names>D</given-names></name><name><surname>Beale</surname><given-names>MH</given-names></name><name><surname>Beger</surname><given-names>R</given-names></name><name><surname>Daykin</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Proposed minimum reporting standards for chemical analysis</article-title><source>Metabolomics</source><year>2007</year><volume>3</volume><issue>3</issue><fpage>211</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1007/s11306-007-0082-2</pub-id><pub-id pub-id-type="pmid">24039616</pub-id></element-citation></ref><ref id="CR56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szyma&#x00144;ska</surname><given-names>E</given-names></name><name><surname>Saccenti</surname><given-names>E</given-names></name><name><surname>Smilde</surname><given-names>AK</given-names></name><name><surname>Westerhuis</surname><given-names>JA</given-names></name></person-group><article-title>Double-check: Validation of diagnostic statistics for PLS-DA models in metabolomics studies</article-title><source>Metabolomics</source><year>2012</year><volume>8</volume><issue>1</issue><fpage>3</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1007/s11306-011-0330-3</pub-id><pub-id pub-id-type="pmid">22593721</pub-id></element-citation></ref><ref id="CR57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Topping</surname><given-names>DL</given-names></name><name><surname>Clifton</surname><given-names>PM</given-names></name></person-group><article-title>Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides</article-title><source>Physiological Reviews</source><year>2001</year><volume>81</volume><issue>3</issue><fpage>1031</fpage><lpage>1064</lpage><pub-id pub-id-type="pmid">11427691</pub-id></element-citation></ref><ref id="CR58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsch&#x000f6;p</surname><given-names>M</given-names></name><name><surname>Smiley</surname><given-names>D&#x00026;</given-names></name><name><surname>Helman</surname><given-names>M</given-names></name></person-group><article-title>Ghrelin induces adiposity in rodents</article-title><source>Nature</source><year>2000</year><volume>407</volume><fpage>908</fpage><lpage>913</lpage><pub-id pub-id-type="doi">10.1038/35038090</pub-id><pub-id pub-id-type="pmid">11057670</pub-id></element-citation></ref><ref id="CR59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitaglione</surname><given-names>P</given-names></name><name><surname>Lumaga</surname><given-names>RB</given-names></name><name><surname>Stanzione</surname><given-names>A</given-names></name><name><surname>Scalfi</surname><given-names>L</given-names></name><name><surname>Fogliano</surname><given-names>V</given-names></name></person-group><article-title>&#x003b2;-Glucan-enriched bread reduces energy intake and modifies plasma ghrelin and peptide YY concentrations in the short term</article-title><source>Appetite</source><year>2009</year><volume>53</volume><issue>3</issue><fpage>338</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1016/j.appet.2009.07.013</pub-id><pub-id pub-id-type="pmid">19631705</pub-id></element-citation></ref><ref id="CR60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>PJ</given-names></name></person-group><article-title>Cereal &#x003b2;-glucans in diet and health</article-title><source>Journal of Cereal Science</source><year>2007</year><volume>46</volume><issue>3</issue><fpage>230</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.jcs.2007.06.012</pub-id></element-citation></ref><ref id="CR61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name><name><surname>Huan</surname><given-names>T</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome</article-title><source>Analytical Chemistry</source><year>2014</year><volume>87</volume><issue>2</issue><fpage>829</fpage><lpage>836</lpage><pub-id pub-id-type="doi">10.1021/ac503619q</pub-id><pub-id pub-id-type="pmid">25486321</pub-id></element-citation></ref></ref-list></back></article>